540395 Stock Overview
Engages in the manufacture and sale of intermediates and chemicals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Chemcrux Enterprises Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹184.90 |
| 52 Week High | ₹326.00 |
| 52 Week Low | ₹182.00 |
| Beta | 0.59 |
| 11 Month Change | -5.03% |
| 3 Month Change | -18.13% |
| 1 Year Change | -34.26% |
| 33 Year Change | 49.23% |
| 5 Year Change | 494.85% |
| Change since IPO | 2,468.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540395 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -2.5% | -0.8% | 0.5% |
| 1Y | -34.3% | 10.7% | 27.5% |
Return vs Industry: 540395 underperformed the Indian Chemicals industry which returned 10.7% over the past year.
Return vs Market: 540395 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 540395 volatility | |
|---|---|
| 540395 Average Weekly Movement | 3.5% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 540395 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 540395's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 98 | Sanjaybhai Marathe | www.chemcrux.com |
Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, aceturic acid, lassamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoyl chloride.
Chemcrux Enterprises Limited Fundamentals Summary
| 540395 fundamental statistics | |
|---|---|
| Market cap | ₹2.74b |
| Earnings (TTM) | ₹72.60m |
| Revenue (TTM) | ₹752.08m |
37.7x
P/E Ratio3.6x
P/S RatioIs 540395 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540395 income statement (TTM) | |
|---|---|
| Revenue | ₹752.08m |
| Cost of Revenue | ₹316.65m |
| Gross Profit | ₹435.43m |
| Other Expenses | ₹362.84m |
| Earnings | ₹72.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.90 |
| Gross Margin | 57.90% |
| Net Profit Margin | 9.65% |
| Debt/Equity Ratio | 37.8% |
How did 540395 perform over the long term?
See historical performance and comparison